Zum Inhalt

CagA-positive H. pylori may protect against disease of the hands, feet, and mouth

  • Open Access
  • 01.12.2025
  • Research
Erschienen in:

Abstract

Background

The incidence of an infection with Helicobacter pylori, or H. pylori rises with age, mostly affecting children.The infection rate of Helicobacter pylori increases with age, primarily affecting children. The rate of cases of disease of the hands, feet, and mouth (HFMD), an infectious illness that mostly affects newborns and young children and is ubiquitous throughout the Asia-Pacific area, declines with age. Asthma, shigellosis, TB, anaphylactic disease, and other diarrheal illnesses are all prevented by H. pylori. It also has a strong correlation with infectious disorders brought on by infection with pathogens including Orientia tsutsugamushi, HIV, HCV, and Brucella abortus. Nonetheless, the status of infection with H. pylori in individuals already infected with HFMD and the clinical implications of CagA+ H. pylori strains remain unreported.

Methods

From October 2020 to October 2023, 130 children clinically diagnosed with HFMD enrolled in the observation group at the Affiliated Hospital of Youjiang Medical University for Nationalities Affiliated Hospital of Youjiang Medical College of Nationalities and the People’s Hospital of Beihai. With respect to gender, age, and location of residence, 150 chronologically matched healthy children made up the control group. Serum H. pylori antibodies in patients were measured, and the strain was identified through the Western blot technique.

Results

1. The frequency of infections with H. pylori with the prevalence of CagA + strains were found to be 16.2% and 8.5%, respectively, in patients with HFMD. These figures are lower than the 29.3% and 18.0% that are seen in healthy children, respectively (P-value < 0.05 for both). 2. The infection rate of the bacteria H. pylori and CagA + strains was found to be 18.5% and 9.3% in HFMD patients over 5 years of age, which is lower than the 41.5% and 26.2% observed in healthy children over 5 years, respectively (P-value < 0.05). In contrast, the rate of H. pylori and CagA + strains in HFMD patients aged 5 years and below was comparable to that of healthy children in the same age group, with both results showing no statistically significant differences. 3. H. pylori and CagA + strain prevalence were similar in primary and subsequent HFMV infections, although neither was statistically significant. 4.The findings of the univariate and multivariate analyses indicated that vaccination against HFMD and infection with H. pylori CagA + were protective factors against HFMD (0.203; 0.069–0.593; 0.004).

Conclusion

When compared to children in good health, individuals with HFMD had much lower levels of Helicobacter pylori infection. Additionally, H. pylori that carries the CagA gene could be able to prevent the development of HFMD.
Qiuying Du, Weifeng Wang and Fenglian Deng contributed equally to this work.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
HFMD
Hand, foot, and mouth disease
H. pylori
Helicobacter pylori
EV71
Enterovirus 71
LTBI
Latent tuberculosis infection

Introduction

Fever, anorexia, and sadness are common symptoms of hand-foot and mouth disease (HFMD), which is an acute infectious disease that affects children and is brought about by enteroviral infections. This disease is characterized by skin rashes, herpes, and blisters on the feet, hands, mouth, and buttocks. Over the past several years, the prevalence of HFMD has remained extremely high in mainland China and other Asia-Pacific areas. Furthermore, the growing number of severe illnesses and fatalities that have been attributed to HFMD has garnered a significant amount of attention from across the world [1].
Hosts harboring the HFMD virus may exhibit latent infection, herpetic pharyngitis, a straightforward rash, or characteristic HFMD. Most occurrences are moderate and self-limiting, but a tiny percentage of cases progress quickly, are linked to serious problems with the central nervous system, and, in severe instances, can result in death from cardiopulmonary failure [1]. Protecting the host from HFMD virus infection is mostly dependent on innate and mucosal immunity [2]. Innate immunity and mucosal immunity are essential components in the process of safeguarding the host against HFMD viral infection [2]. On the other hand, immunity in cells is primarily responsible for the elimination of the virus within the host after the infection has been established.cellular immunity is primarily responsible for eliminating cells infected by viruses. Children with HFMD exhibit diminished levels of CD3 + T, CD4 + T, CD8 + T, CD4+/CD8+, and Th cells, particularly in severe cases, as indicated by certain studies [3, 4]. This suggests that cellular immunity is inadequate in these children. Additionally, it has been observed that the blood of patients with HFMD has a lower percentage of Treg cells. As a result, it is thought that T cell activation in patients infected with EV71 may be down-regulated, indicating that the Th1/Th2 and Th17/Treg ratios in these patients may be unbalanced [5]. After infection, the microaerobic, gram-negative bacteria known as Helicobacter pylori (H. pylori) continues to colonize the mucosa of the stomach for the rest of the patient’s life, which leads to chronic persistent infection. Recent research has increasingly concentrated on the relationship between H pylori and extra-gastrointestinal diseases [6]. Research has indicated that infections brought on by viruses including HIV, HCV, and Borrelia burgdorferi are linked to H. pylori infection [79]. Additionally, studies have demonstrated that H. pylori may offer protection against tuberculosis, atopy, asthma, shigellosis, and other diarrheal illnesses [1012]. Childhood H. pylori infection permanently changes naïve T cells into Th1 phenotypes and causes high levels of Treg cells both locally and systemically. Treg cells are a type of cells with immunoregulatory functions that keep the immune system in balance. It provides theoretical support for the “hygiene hypothesis,” which holds that early infection exposure helps the immune system mature and makes it easier to respond to previous or current infections [10]. Besides, H. pylori needs a healthy immune system in order to colonize the human stomach mucosa successfully and persistently. Studies have shown that H. pylori-related inflammatory environment selectively increases [13] in CD4 + T cells, which plays an important role in the host’s immune response to viral infection. H. pylori expresses virulence proteins, with CagA being a significant one. It’s a key effector protein in H. pylori’s interaction with the host. CagA-positive people can also be stimulated to produce potent cytokines [14]. It has also been demonstrated that H. pylori promotes the production of IL-10 by regulatory T cells in order to regulate local inflammation and maintain immunological homeostasis [15]. This immune response is enhanced in infections caused by the cagA+/vacA s1m1 strain. These immunological pathways cause the connections between H. pylori and other infectious illnesses. Likewise, our group has shown in earlier research that scrub typhus is both facilitated and intensified by CagA + H. pylori infection due to impacts on host immunity [16].
In conclusion, the range of symptoms and clinical regression associated with HFMD varies greatly following host infection with the HFMD virus. Although the precise mechanism underlying this variation remains unclear, It has been proposed that there may be a connection among the immune system of the patient and a particular type of the HFMD virus [17, 18]. HFMD and H. pylori infections are two disorders that may be transmitted via the gastrointestinal system. For the most part, the symptoms of both conditions manifest themselves in youngsters. Our theory is that H. pylori infection may influence the host’s resistance to the HFMD virus, hence impacting the clinical spectrum of HFMD. The aim of this research was to determine if HFMD and H. pylori, particularly CagA + strains, are related.

Materials and methods

General information

The observation group consisted of 130 clinically diagnosed cases of HFMD in children between October 2020 and October 2023 at the Affiliated Hospital of Youjiang Medical University for Nationalities Affiliated Hospital of Youjiang Medical College of Nationalities and Beihai People’s Hospital. Table 1 provides specifics about the 130 HFMD patients’ baseline characteristics. A total of 150 kids from the same period, matched for age and gender for medical examinations, made up the control group. Criteria for diagnosing HFMD: The Hand, Foot, and Mouth Disease Diagnostic and Treatment Guidelines (2018 edition) [19] state that hospitalized children with HFMD who satisfied the clinical diagnostic criteria were included. The primary symptoms of HFMD are rashes on the hands, feet, mouth, and buttocks, which can be accompanied by fever. Severe cases of HFMD may also show neurological involvement, respiratory failure, and other manifestations [20]. Both of the hospitals’ separate ethical review committees gave their approval to the research. Before the study was conducted all patients and minor patient guardians/parents were informed of the pros and cons of participating in the program. all patients and minor patient guardians/parents were informed of the pros and cons of participating in the program. They all volunteered to take part in the trial and completed the appropriate informed permission form.

Methodology

Peripheral blood was collected from all subjects, and H. pylori antibodies were detected utilizing immunoblotting (Shenzhen Burroughs Biological Co., Ltd.). The material used was obtained about Shenzhen Burroughs Biological Co. (production lot number: 161216), and the experimental procedures were conducted in strict accordance with the provided instructions. The immunoblotting technique identifies H. pylori antibodies targeting cytotoxin CagA (bands at 128 kD and 116 kD), vacuole toxin-associated protein VacA (bands at 95 kD and 91 kD), urease ureB (66 kD), and urease ureA (30 kD). Diagnostic criteria: (1) H. pylori strain infection is diagnosed if either or both of urease A and urease B are positive; (2) CagA + strain infection is diagnosed if condition (1) is met and either or both of CagA and VacA are positive (Fig. 1) and (Table 1) .
Table 1
Comparative analysis of general characteristics in H. pylori positive versus H. pylori negative HFMD patients
Attributes
Hand, foot, and mouth disease
(n = 130)
χ²/Fisher’s exact
P-value
H.pylori positive (n = 21)
H.pylori negative (n= 109)
Male, n (%)
13(61.9)
64(58.7)
0.019
0.891
Age, n (%), yr
  
0.381
0.537
≤ 5 years (n = 76)
11(52.4)
65(59.6)
  
>5 years (n = 54)
10(47.6)
44(40.4)
  
Residency, n(%)
  
1.142
0.285
Rural (n = 37)
8(38.1)
29(26.6)
  
Urban (n = 93)
13(61.9)
80(73.4)
  
Number of infections,
n(%)
  
Fisher’s exact test
0.213
Primary (n = 118)
21(100.0)
97(89.0)
  
Secondary (n = 12)
0(0.0)
12(11.0)
  
Vaccination, n(%)
  
0.012
0.913
Yes (n = 42)
7(33.3)
35(32.1)
  
No (n = 88)
14(66.7)
74(67.9)
  
Data are presented as n (%). P values were calculated using Pearson’s χ² test, except that Fisher’s exact test was applied when the expected frequency in any cell was < 5
Fig. 1
Roadmap of the experiment
Bild vergrößern

Statistical methods

Statistical analysis was conducted using SPSS 19.0 software. All variables in this study were categorical and were presented as the number of cases and percentages. Comparisons between groups were performed using the χ² test, or Fisher’s exact test when any expected frequency was < 5 or when a zero cell count occurred. Logistic regression analysis was employed to examine the influencing factors. The difference was deemed statistically significant at P < 0.05.

Results

CagA + and H. pylori strains’ infection status among kids in HFMD

The infection status of H.pylori and CagA + strains in the subjects was analyzed.The results showed that the infection rate of H.pylori and CagA + strains in HFMD children was 16.2% (21/130) and 8.5% (11/130)༈11/130༉, compared to 29.3% (44/150) (χ2 = 0.876, P = 0.039) and 18%(27/150) (χ2 = 4.274, P = 0.042) in the healthy control group, respectively. The differences were statistically significant (Fig. 2).
Fig. 2
Classification of Helicobacter pylori in individuals with HFMD
Bild vergrößern

Assessment about Helicobacter pylori infection status or CagA + strains for patients with hand, foot, and mouth disease, categorized by age

The H.pylori and CagA + strain infection status of the subjects were further analyzed by age stratification, The results showed that in the age group of less than 5 years, the infection rate of H.pylori and CagA + strains was 14.5%(11/76) and 7.9%(6/76), respectively, in HFMD children, They were close to 20.0% (17/85) (χ2 = 0.602, P = 0.438) and 14.1% (10/85) (χ2 = 0.551, P = 0.458) of the healthy control group children, respectively, with no statistical difference; In the > 5 years old age group, the infection rate of H.pylori and CagA + strains in HFMD children was 18.5% (10/54) and 9.3%(5/54), respectively, which were lower than that of healthy control children 41.5% (27/65) (χ2 = 3.929, P = 0.047) and 26.2% (17/65) (χ2 = 3.915, P = 0.048), respectively, with statistical significance (Fig. 3).
Fig. 3
Age stratified Helicobacter pylori and CagA + strain infection status in hand, foot, and mouth disease patients
Bild vergrößern

Helicobacter pylori and CagA + strain infections in hand-foot-mouth disease clients incidence of infections

Among a total of 130 HFMD patients, 118 were first-time patients and 12 were at least twice affected. The infection status of H.pylori and CagA + strains was analyzed.The results showed that the infection rate of H.pylori and CagA + strains in children with recurrent HFMD were all 0(0/12), which was lower than that of children with initial HFMD at 13.9% (21/118)and 7.4%(11/118), respectively, and the difference was not statistically significant (Fig. 4).
Fig. 4
H. pylori and CagA + infections in patients with HFMD (based on number of infections)
Bild vergrößern
.
`The comprehensive factors that may affect the occurrence and development of HFMD were analyzed.The results of multiple regression analysis show that HFMD vaccination (0.484,0.291–0.806,0.005) and CagA + H. pylori infection (0.306,0.140–0.672,0.003) were independent protective factors for HFMD (Table 2).
Table 2
Univariate and multivariate analysis of the relationship between H. pylori infection and HFMD
 
Univariate analysis
Multivariate analysis
OR (95% CI)
P-value
OR (95% CI)
P-value
Male sex
1.116(0.696–1.788)
0.649
1.128(0.691–1.839)
0.630
Age>5y
0.929(0.578–1.495)
0.762
1.050(0.639–1.726)
0.847
Living in non-urban areas
1.132(0.668–1.919)
0.644
1.211(0.701–2.093)
0.492
Vaccination
0.560(0.344–0.913)
0.020
0.484(0.291–0.806)
0.005
H. pylori infection
0.464(0.259–0.833)
0.010
1.284(0.726–2.211)
0.387
CagA + H. pylori
0.396(0.187–0.839)
0.016
0.306(0.140–0.672)
0.003

Discussion

The majority of H. pylori infections happen in childhood, and if treatment is not successful, infections frequently last a lifetime [21]. However, enterovirus-induced HFMD is more common in children under five. In clinical terms, HFMD diminishes with age, but H. pylori increases. Therefore, a thorough consideration of the potential clinical relationship between the two is warranted. We investigated the association between the two for the first time in the current study. In order to reduce the impact of age, gender, and geographic variables, we carefully matched the age, gender, and regional distribution of children with HFMD with those of healthy children who underwent medical examinations.
Children with HFMD had a substantially lower infection in the bacteria H. pylori (16.2% against 29.3%, P < 0.05) than children who had healthy check-ups, according to first-time results in this study. This suggests that H. pylori infection may have a protective effect against HFMD. Children over five years old exhibited a considerably lower likelihood of infections caused by H. pylori (18.5% compared to 41.5%, P < 0.05) than children without HFMD, according to the results of this study’s further age stratification. Still, this phenomenon was not observed in children younger than five years old. It could also be a significant factor in the frequency of HFMD declining with age and being more common in children under the age of five. The exact mechanism underlying this phenomenon remains ambiguous; nonetheless, during an intestinal H. pylori infection, neutrophils, B lymphocytes, and T lymphocytes infiltrate the stomach and duodenal mucosa. This infiltration does not result in H. pylori clearance, which could be caused by insufficient cytokine secretion or by the immune system being down-regulated because of the increased number of regulatory cells(Tregs) that are present [22]. Additional research has demonstrated that during Helicobacter infection, there is an increase in Tregs, which results in a reduction in the rate of cytokine production [2325]. There may be a connection between the immunosuppression of Tregs and the survival and persistence of some infectious pathogens, as evidenced by the association between increased Tregs activity and the stability of illnesses, including leishmaniasis, malaria, and tuberculosis [26]. According to the “hygiene hypothesis,” which was progressively developed by Strachan [27] and Bach [28], childhood exposure to microorganisms strengthens the immune system, may prevent the onset of autoimmune diseases in adulthood, and improves the body’s ability to respond to previous or current infections [29]. In the lack for H. pylori infection, the processes that may be participating may include, on the one hand, insufficient microbial stimulation if gut-associated lymphoid tissues, which is an essential location for the development of the mucosal immune system [30]. Conversely, childhood getting ill with H. pylori can lead to the permanent differentiation of naïve T cells into a Th1 phenotype and induce elevated levels of Treg cells both locally and systemically [10]. Innate immunity and mucosal immunity have a major role in the host’s resistance to the virus during the early stages of HFMD viral infection [2]. The “hygiene hypothesis” suggests that prior contact with H. pylori plays an instrumental part in the establishment about intestinal mucosal immunity, potentially explaining the protective effect of H. pylori getting sick against HFMD. Studies also indicate that it may exhibit a synergistic effect in conjunction with EV71 infection. Ammar M. Hassanbhai [31] et al. Constructed a model of EV71 interaction with dehydrated H. pylori biofilm to simulate the relationship between the two in the natural state of the environment. The study found that EV71 was more likely to survive and replicate in the presence of H.pylori biofilm, and that the number of biofilms determined the viral viability. This suggests that H.pylori biofilms may provide an alternate route for EV71 transmission, as the study suggests that EV71 particles are protected from degradation and inactivation by synergistic interactions with Helicobacter pylori.
Furthermore, by causing bystander effects through prolonged inflammation and T-cell signaling, H. pylori infection may enhance innate immune responses to other infectious illnesses [10]. When Listeria monocytogenes and Yersinia pestis attack mice, infectious diarrhea rarely occurs, similar to mice with herpesvirus infection [10].
While most childhood H. pylori infections do not cause any symptoms, a small percentage of infected people get gastrointestinal or extragastrointestinal disease. An assortment of variables may be at issue here, like the genetic composition of the hosts and the aggressiveness of those from H. pylori strains, namely the CagA + ones [14]. We used immunoblotting to figure out the presence of H. pylori strains while investigating the association involving these strains and HFMD in this research. The findings revealed that HFMD patients were more likely to have a smaller percentage of H. pylori CagA + strain infection compared to healthy control (8.5% vs. 18.0%, P < 0.05). likewise, in children who were over five years old, HFMD children were more bound to have a lower prevalence of CagA + H. pylori infection than healthy control (9.3% vs. 26.6%, P < 0.05), with a statistically significant difference. The results of multivariate regression analyses strengthened the hypothesis that H. pylori CagA + strain infection was a protective marker for HFMD. The results indicate that pylori bacteria harboring the CagA gene may confer an immune defense against HFMD, although it is unclear exactly how this protective effect works. According to research, H. pylori infections mostly cause a Th1/Th17 response [15]. Moreover, infections with the cagA+/vacA s1m1 strain had a stronger immune response than those with the cagA-/vacA s2/m2 strain [15]. IL-17 expressed following an infestation of H. pylori has been illustrated to increase early host resistance to Mycobacterium colonization in LTBI and trigger T-cell migration to the lungs [15]. On the other hand, Kienesberger et al. [32] also discovered that a significant factor in either tuberculosis susceptibility or protection is the H. pylori-induced migration of Treg and Th17 cells to distant regions, particularly high pathogenicity (CagA+) strains. We hypothesized that H. pylori infection harboring the the enzyme CagA gene contributes to the pathogenesis of HFMD via a comparable mechanism.
In the final analysis, HFMD patients had a considerably lower prevalence of H.pylori infection juxtaposed to the appropriate population. Furthermore, the type I H.pylori strain has been demonstrated to be an standalone safeguarding factor for the emergence of HFMD, demonstrating that H.pylori transporting the CagA gene might constitute an inhibitor of infection.
This study might have some drawbacks. The present investigation employed the immunoblotting approach, which is user-friendly and possesses high specificity and sensitivity, to determine the blood H. pylori antibodies and identify its strains. However, studies utilizing serology are also vulnerable to data bias, and we did not conduct duplicate testing to decrease error. Second, this paper only examined serological testing as our primary method of data analysis. It did not include other potential risk factors for H. pylori infection, in particular the family revenue, antibiotic usage, as well as the existence or absence of a presenting ailments.

Acknowledgements

We are highly grateful to Beihai People’s Hospital and the Affiliated Hospital of Youjiang Medical University for Nationalities.

Declarations

I have read and followed the journal policy on ethical consent and animal care standards in the Author’s Guide. Our work involves the use of human subjects, we ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans.
We declare in the manuscript that we have obtained informed consent for human experiments(Ethical review number isYYFY-LL-GCCRC-001) and always adhere to the privacy rights of human subjects.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Download
Titel
CagA-positive H. pylori may protect against disease of the hands, feet, and mouth
Verfasst von
Qiuying Du
Weifeng Wang
Fenglian Deng
Jianyu Cao
Xiaoxian Wei
Zengjing Liu
Chunyi Long
Jing Pan
Liudan Liang
Guangfu Pang
Yuefeng Huang
Shengkui Tan
Jiannan Lv
Publikationsdatum
01.12.2025
Verlag
BioMed Central
Erschienen in
Gut Pathogens / Ausgabe 1/2025
Elektronische ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-025-00763-8
1.
Zurück zum Zitat Zhao TS, Du J, Sun DP, Zhu QR, Chen LY, Ye C, et al. A review and meta-analysis of the epidemiology and clinical presentation of coxsackievirus A6 causing hand-foot-mouth disease in China and global implications. Rev Med Virol. 2020;30(2):e2087. https://doi.org/10.1002/rmv.2087.CrossRefPubMed
2.
Zurück zum Zitat Gong S, Nan N, Sun Y, He Z, Li J, Chen F, et al. Protective immunity elicited by VP1 chimeric antigens of bacterial ghosts against Hand-Foot-and-Mouth disease virus. Vaccines (Basel). 2020. https://doi.org/10.3390/vaccines8010061.CrossRefPubMed
3.
Zurück zum Zitat Wang J, Zheng JS, Zhang YH. The comparisons of procalcitonin and age between mild and severe hand, foot, and mouth disease. Transl Pediatr. 2023;12(4):663–9. https://doi.org/10.21037/tp-23-146.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Li X. A study of variation of cellular immunity in severe Hand-Foot-Mouth disease [重症手足口病细胞免疫功能变化的研究]. Guangxi Medical University; 2017.
5.
Zurück zum Zitat Zhao MQ, Wang LH, Lian GW, Lin ZF, Li YH, Guo M, et al. Characterization of lymphocyte subsets in peripheral blood cells of children with EV71 infection. J Microbiol Immunol Infect. 2020;53(5):705–14. https://doi.org/10.1016/j.jmii.2019.03.001.CrossRefPubMed
6.
Zurück zum Zitat Wang J, Dong F, Su H, Zhu L, Shao S, Wu J, et al. H. pylori is related to NAFLD but only in female: a cross-sectional study. Int J Med Sci. 2021;18(11):2303–11. https://doi.org/10.7150/ijms.50748.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Guo L, Wang W, Chen F et al. Research Progress on the Relationship Between Helicobacter pylori Infection and AIDS [幽门螺杆菌感染与艾滋病之间关系的研究进展]. Chinese Journal of Infectious Diseases 2021;39(3):5. https://doi.org/10.3760/cma.j.cn311365-20200219-00091
8.
Zurück zum Zitat Furusyo N, Walaa AH, Eiraku K, Toyoda K, Ogawa E, Ikezaki H, et al. Treatment for eradication of Helicobacter pylori infection among chronic hepatitis C patients. Gut Liver. 2011;5(4):447–53. https://doi.org/10.5009/gnl.2011.5.4.447.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Afrasiabian S, Mohsenpour B, Ghaderi E, Nadri S, Hajibagheri K. Does Helicobacter pylori infection play a role in susceptibility to brucellosis? Jpn J Infect Dis. 2017;70(6):672–4. https://doi.org/10.7883/yoken.JJID.2017.043.CrossRefPubMed
10.
Zurück zum Zitat Perry S, de Jong BC, Solnick JV, de la Luz Sanchez M, Yang S, Lin PL, et al. Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS ONE. 2010;5(1):e8804. https://doi.org/10.1371/journal.pone.0008804.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Blaser MJ, Chen Y, Reibman J. Does Helicobacter pylori protect against asthma and allergy? Gut. 2008;57(5):561–7. https://doi.org/10.1136/gut.2007.133462.CrossRefPubMed
12.
Zurück zum Zitat Cohen D, Shoham O, Orr N, Muhsen K. An inverse and independent association between Helicobacter pylori infection and the incidence of shigellosis and other diarrheal diseases. Clin Infect Dis. 2012;54(4):e35–42. https://doi.org/10.1093/cid/cir916.CrossRefPubMed
13.
Zurück zum Zitat Nevin DT, Morgan CJ, Graham DY, Genta RM. Helicobacter pylori gastritis in HIV-infected patients: a review. Helicobacter. 2014;19(5):323–9. https://doi.org/10.1111/hel.12131.CrossRefPubMed
14.
Zurück zum Zitat Bridge DR, Merrell DS. Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease. Gut Microbes. 2013;4(2):101–17. https://doi.org/10.4161/gmic.23797.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Bustamante-Rengifo JA, Astudillo-Hernández M, Del Crespo-Ortiz P. Effect of Helicobacter pylori and helminth coinfection on the immune response to Mycobacterium tuberculosis. Curr Microbiol. 2021;78(9):3351–71. https://doi.org/10.1007/s00284-021-02604-8.CrossRefPubMed
16.
Zurück zum Zitat Du Q, Zeng H, Pang X, Cao J, Xie B, Long C, et al. CagA-positive Helicobacter pylori may promote and aggravate scrub typhus. Front Microbiol. 2024;15:1351784. https://doi.org/10.3389/fmicb.2024.1351784.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Wei J, Lv L, Wang T, Gu W, Luo Y, Feng H. Recent progress in innate immune responses to enterovirus A71 and viral evasion strategies. Int J Mol Sci. 2024. https://doi.org/10.3390/ijms25115688.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Chen KR, Ling P. Interplays between enterovirus A71 and the innate immune system. J Biomed Sci. 2019;26(1):95. https://doi.org/10.1186/s12929-019-0596-8.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat China NHCotPsRo. Diagnosis and Treatment Guideline on Hand, Foot and Mouth, Disease. (2018)[手足口病诊疗指南(2018年版)]. Chinese Journal of Clinical Infectious Diseases 2018;11(3):161-6. https://doi.org/10.3760/cma.j.issn.1674-2397.2018.03.001
20.
Zurück zum Zitat Zhu P, Ji W, Li D, Li Z, Chen Y, Dai B, et al. Current status of hand-foot-and-mouth disease. J Biomed Sci. 2023;30(1):15. https://doi.org/10.1186/s12929-023-00908-4.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Frenck RW Jr., Clemens J. Helicobacter in the developing world. Microbes Infect. 2003;5(8):705–13. https://doi.org/10.1016/s1286-4579(03)00112-6.
22.
Zurück zum Zitat Hu F, Zhou D. Helicobacter pylori infection: basic and clinical aspects [幽门螺杆菌感染的基础与临床]. 3rd ed. ed. China Science and Technology; 2009.
23.
Zurück zum Zitat Wang KY, Li SN, Liu CS, Perng DS, Su YC, Wu DC, et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr. 2004;80(3):737–41. https://doi.org/10.1093/ajcn/80.3.737.CrossRefPubMed
24.
Zurück zum Zitat Park SK, Park DI, Choi JS, Kang MS, Park JH, Kim HJ, et al. The effect of probiotics on Helicobacter pylori eradication. Hepatogastroenterology. 2007;54(79):2032–6. https://doi.org/10.1080/10428190310001593157.CrossRefPubMed
25.
Zurück zum Zitat Ismail TF, Smits H, Wasfy MO, Malone JL, Fadeel MA, Mahoney F. Evaluation of dipstick serologic tests for diagnosis of brucellosis and typhoid fever in Egypt. J Clin Microbiol. 2002;40(9):3509–11. https://doi.org/10.1128/jcm.40.9.3509-3511.2002.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4 + CD25 + regulatory T cells control leishmania major persistence and immunity. Nature. 2002;420(6915):502–7. https://doi.org/10.1038/nature01152.CrossRefPubMed
27.
Zurück zum Zitat Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. https://doi.org/10.1186/1471-2288-14-135.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278–86. https://doi.org/10.1212/wnl.0000000000000560.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Arjmandi D, Abdollahi A, Ardekani A, Razavian I, Razavian E, Sartip B, et al. Helicobacter pylori infection and risk of multiple sclerosis: an updated meta-analysis. Helicobacter. 2022;27(6):e12927. https://doi.org/10.1111/hel.12927.CrossRefPubMed
30.
Zurück zum Zitat Ram M, Barzilai O, Shapira Y, Anaya JM, Tincani A, Stojanovich L, et al. Helicobacter pylori serology in autoimmune diseases - fact or fiction? Clin Chem Lab Med. 2013;51(5):1075–82. https://doi.org/10.1515/cclm-2012-0477.CrossRefPubMed
31.
Zurück zum Zitat Hassanbhai AM, Phoon MC, Chow VT, Ho B. The association of Helicobacter pylori biofilm with enterovirus 71 prolongs viral viability and survival. Int J Mol Sci. 2023. https://doi.org/10.3390/ijms241914500.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Kienesberger S, Cox LM, Livanos A, Zhang XS, Chung J, Perez-Perez GI, et al. Gastric Helicobacter pylori infection affects local and distant microbial populations and host responses. Cell Rep. 2016;14(6):1395–407. https://doi.org/10.1016/j.celrep.2016.01.017.CrossRefPubMedPubMedCentral

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Fokale Salvage-Therapie bei lokalem Prostatakrebsrezidiv langfristig wirksam

Bei einem nach Radiotherapie lokal rezidivierten Prostatakarzinom sind fokale Salvage-Therapien mit einer guten Prognose verbunden: Das krebsspezifische Zehn-Jahres-Überleben ist einem retrospektiven Vergleich zufolge ebenso hoch wie nach Salvage-Prostatektomie.

Relacorilant verlängert Überleben bei platinresistentem Ovarialkarzinom

Durch Hinzunahme des Glukokortikoid-Rezeptor-Antagonisten Relacorilant zu nab-Paclitaxel wird bei Frauen mit platinresistentem Ovarialkarzinom nicht nur das progressionsfreie, sondern auch das Gesamtüberleben verlängert. Laut finaler Analyse der ROSELLA-Studie gewinnen sie vier Monate an Lebenszeit.

ICI-induzierte Dermatitis: Upadacitinib als vielversprechende Therapieoption

Immunvermittelte Hautreaktionen gehören zu den häufigsten Nebenwirkungen von Immun‑Checkpoint‑Inhibitoren. Eine offene Phase‑2‑Studie untersuchte den JAK‑1‑Inhibitor Upadacitinib bei schwerer ICI‑assoziierter Dermatitis. Die Hautsymptome gingen rasch zurück, schwerwiegende therapieassoziierte Nebenwirkungen wurden nicht beobachtet.

Extrapulmonale Befunde beim Lungenkrebs-Screening – Krebsverdacht gerechtfertigt?

Der Umgang mit Zufallsentdeckungen ist ein vieldiskutiertes Thema im Zusammenhang mit dem Low-Dose-CT-Screening auf Lungenkrebs. Eine Studie hat sich nun speziell mit inzidentellen Befunden befasst, die auf ein extrapulmonales Malignom verdächtig sind.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, Eine Person kratzt sich am Rücken über der Schulter/© ryanking999 / stock.adobe.com (Symbolbild mit Fotomodell), Mann erhält einen CT-Scan /© Mark Kostich / stock.adobe.com (Symbolbild mit Fotomodell)